Evidence map›Paper›PMID 33898975›Full record

ArticlePlant communications2021

High-efficiency genome editing in plants mediated by a Cas9 gene containing multiple introns.

Ramona Grützner, Patrick Martin, Claudia Horn, Samuel Mortensen, Erin J Cram, Carolyn W T Lee-Parsons, Johannes Stuttmann, Sylvestre Marillonnet

Open access · goldAbstract read
In one paragraph

Article in Plant communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 236 citations in OpenAlex.

  1. Characterization ofSynthetic and systems biotechnology · 2027
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Wheat's Up with CRISPR-Cas-Current Advances, Obstacles and Perspectives.International journal of molecular sciences · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Automated Genetic Engineering in the Laboratory.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  20. Development ofFrontiers in genome editing · 2026
    Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ramona GrütznerDepartment of Cell and Metabolic Biology, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120 Halle (Saale), Germany.
Patrick MartinInstitute for Biology, Department of Plant Genetics, Martin Luther University Halle-Wittenberg, Weinbergweg 10, 06120 Halle (Saale), Germany.
Claudia HornDepartment of Cell and Metabolic Biology, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120 Halle (Saale), Germany.
Samuel MortensenDepartment of Biology, Northeastern University, Boston, MA, USA.
Erin J CramDepartment of Biology, Northeastern University, Boston, MA, USA.
Carolyn W T Lee-ParsonsDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, MA, USA.
Johannes StuttmannInstitute for Biology, Department of Plant Genetics, Martin Luther University Halle-Wittenberg, Weinbergweg 10, 06120 Halle (Saale), Germany.
Sylvestre MarillonnetDepartment of Cell and Metabolic Biology, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120 Halle (Saale), Germany.
Leibniz Institute of Plant Biochemistry · DENortheastern University · USMartin Luther University Halle-Wittenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent discovery of the mode of action of the CRISPR/Cas9 system has provided biologists with a useful tool for generating site-specific mutations in genes of interest. In plants, site-targeted mutations are usually obtained by the stable transformation of a Cas9 expression construct into the plant genome. The efficiency of introducing mutations in genes of interest can vary considerably depending on the specific features of the constructs, including the source and nature of the promoters and terminators used for the expression of the Cas9 gene and the guide RNA, and the sequence of the Cas9 nuclease itself. To optimize the efficiency of the Cas9 nuclease in generating mutations in target genes in

Indexed as

CRISPR-Cas SystemsGenome, PlantIntronsArabidopsisArabidopsis ProteinsCRISPR-Associated Protein 9Gene EditingArabidopsis ProteinsCRISPR-Associated Protein 9Cas9CRISPRgene targetingtargeted mutagenesis

Identifiers

PMID33898975
PMCPMC8060730
OpenAlexW3108046194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.